Antiestrogen vs Aromatase Inhibitor After Adjuvant Chemotherapy for Breast Cancer
Status:
Terminated
Trial end date:
2020-05-01
Target enrollment:
Participant gender:
Summary
To investigate the benefit of postoperative adjuvant therapy using sequential administration
of the hormone, toremifene citrate (TOR) or anastrozole (ANA), after chemotherapy in breast
cancer.